Related Experiment Video
Updated: Jun 18, 2026
12:46
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
Targeting polymorphonuclear leukocytes in acute myocardial infarction
Clara Di Filippo1, Francesco Rossi, Michele D'Amico
1Department of Experimental Medicine, Section of Pharmacology L. Donatelli, 2nd University of Naples, Naples, Italy.
Thescientificworldjournal
|March 6, 2007
Summary
Polymorphonuclear leukocytes (PMNs) play a key role in acute myocardial infarction (AMI) pathogenesis. Targeting PMN activity and related signaling pathways, like PI3Kg, may improve patient prognosis in cardiovascular diseases.
Area of Science:
- Cardiovascular Research
- Immunology
- Pathogenesis of Myocardial Infarction
Background:
- Acute myocardial infarction (AMI) significantly impacts patient morbidity and mortality.
- The precise mediators and pathways driving AMI etiology remain an active area of research.
Purpose of the Study:
- To review the emerging role of polymorphonuclear leukocytes (PMNs) in AMI pathogenesis.
- To discuss the potential therapeutic benefits of inhibiting PMN activity and associated signaling pathways in AMI.
- To present new data on phosphoinositide 3-kinase gamma (PI3Kg) in neutrophil recruitment during AMI.
Main Methods:
- Literature review of past and ongoing research on PMNs in AMI.
- Analysis of signaling pathways involved in PMN activation and recruitment.
- Discussion of novel findings regarding PI3Kg's role in neutrophil migration.
Main Results:
- Polymorphonuclear leukocytes (PMNs) are increasingly recognized as critical mediators in AMI.
- Inhibition of PMN activity shows promise for improving AMI outcomes.
- Phosphoinositide 3-kinase gamma (PI3Kg) is implicated in neutrophil recruitment during myocardial infarction.
Conclusions:
- Targeting PMN function represents a potential therapeutic strategy for AMI.
- Understanding PI3Kg's role in neutrophil recruitment could lead to novel treatment approaches for cardiovascular diseases.
More Related Videos
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...